Shares of Krystal Biotech (KRYS +1.32%) were up more than 15% Monday morning. The company announced on Friday that it had received Food and Drug Administration (FDA) approval for Vyjuvek (beremagene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results